Sugi Predict

Sugi Predict / Compounds / SCHEMBL6016966

SCHEMBL6016966

SCHEMBL6016966

Fc1ccc(-c2nc(Cl)nc(Cl)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TXN P10599 1/20 0.55
▸ NPC1 O15118 5/20 0.41
▸ RAB9A P51151 5/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ DHPS P49366 1/20 0.40
▸ DPP4 P27487 2/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ ABCG2 Q9UNQ0 1/20 0.37
▸ AHR P35869 1/20 0.37
▸ BCL2L1 Q07817 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6017041 0.95 TXN (0.50) TXNNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL20967403 0.87 MEN1 (0.50) TXNNPC1SMN1; SMN2KMT2AMEN1
SCHEMBL30834580 0.87 MEN1 (0.50) TXNNPC1SMN1; SMN2KMT2AMEN1
SCHEMBL25844629 0.86 MEN1 (0.48) TXNNPC1SMN1; SMN2KMT2AMEN1
SCHEMBL27774680 0.86 NPC1 (0.57) TXNNPC1RAB9AKMT2AMEN1
SCHEMBL6017000 0.82 RAB9A (0.47) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL11400612 0.80 NPC1 (0.60) NPC1RAB9ASMN1; SMN2TSHRKMT2A
SCHEMBL31701989 0.80 CYP1A2 (0.47) TXNSMN1; SMN2TP53HSD17B10KMT2A
SCHEMBL23733877 0.79 BCL2L1 (0.48) TXNNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL17269527 0.79 BCL2L1 (0.48) TXNNPC1RAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11910709-B2 Organic compound, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-02-20 — — US disclosed
US-20230301182-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-09-21 — — US disclosed
US-20230301182-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-09-21 — — US disclosed
CN-114230562-B Heterocyclic compound, and electronic component and electronic device including the same 陕西莱特迈思光电材料有限公司 2023-07-14 — — CN disclosed
CN-109384802-B Heterocyclic compound, and organic light-emitting device and electronic device including same 三星显示有限公司（KR） 2023-01-13 — — CN disclosed
CN-114230562-A Heterocyclic compound, and electronic element and electronic device comprising same 陕西莱特迈思光电材料有限公司 2022-03-25 — — CN disclosed
CN-111747937-B 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2022-01-14 — — CN disclosed
US-10903432-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-01-26 — — US disclosed
CN-111747937-A 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2020-10-09 — — CN disclosed
WO-2020199998-A1 1,3,5-TRIAZINE COMPOUND AND COMPOSITION, AND APPLICATION THEREOF 吉林省元合电子材料有限公司 2020-10-08 — — WO disclosed
EP-3441391-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2020-09-02 — — EP disclosed
US-20190051841-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-14 — — US disclosed
EP-3441391-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Samsung Display Co., Ltd. (KR) 2019-02-13 — — EP disclosed
EP-3441391-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Samsung Display Co., Ltd. (KR) 2019-02-13 — — EP disclosed
US-7749617-B2 Organic compound and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2010-07-06 — — US disclosed
US-7749617-B2 Organic compound and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2010-07-06 — — US disclosed
US-20060252857-A1 Aminoaryl-1-3-5-triazines and their use as uv absorbers SCHAEFER THOMAS 2006-11-09 — — US disclosed
EP-1641768-A2 AMINOARYL-1-3-5 TRIAZINES AND THEIR USE AS UV ABSORBERS Ciba SC Holding AG (CH) 2006-04-05 — — EP disclosed
WO-2004106311-A2 AMINOARYL-1-3-5 TRIAZINES AND THEIR USE AS UV ABSORBERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-12-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11910709-B2 Organic compound, and electronic element and electronic device using same OR10J3, ESR1, EPCAM TXN 2097/4885NPC1 2161/4885RAB9A 2813/4885
US-20060252857-A1 Aminoaryl-1-3-5-triazines and their use as uv absorbers IK, CRY2, CRY1 TXN 2528/4885NPC1 3565/4885RAB9A 3061/4885
US-20190051841-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, CYP1A1, CRY1 TXN 3299/4885NPC1 3331/4885RAB9A 3129/4885
US-20230301182-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME OR10J3, ESR1, EPCAM TXN 2097/4885NPC1 2161/4885RAB9A 2813/4885
US-10903432-B2 Heterocyclic compound and organic light-emitting device including the same AOC2, CYP1A1, CRY1 TXN 3299/4885NPC1 3331/4885RAB9A 3129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.